Your Source for Venture Capital and Private Equity Financings

Ensoma Launches with $70M in Series A

2021-02-12
BOSTON, MA, Ensoma, a genomic medicine company, has launched with a $70 million Series A financing led by co-founder and seed investor 5AM Ventures.
Ensoma, a genomic medicine company, has launched with a $70 million Series A financing led by co-founder and seed investor 5AM Ventures, with participation from F-Prime Capital, Takeda Ventures, Viking Global Investors, Cormorant Asset Management, RIT Capital Partners, Symbiosis II, LLC, and Alexandria Venture Investments.

Ensoma's Engenious platform has been extensively validated in numerous preclinical models with a range of genome editing technologies, demonstrating robust genetic modification of bone marrow HSCs and stable long-term expression of therapeutic proteins in small and large preclinical models.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading